Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2024

Open Access 01-12-2024 | Vancomycin | Research

Prophylactic use of vancomycin powder on postoperative infection after total joint arthroplasty

Authors: Jian Gao, Li Shu, Kan Jiang, Aikeremujiang Muheremu

Published in: BMC Musculoskeletal Disorders | Issue 1/2024

Login to get access

Abstract

Objective

By reviewing the literature analyzing vancomycin powder for preventive surgery, the effect of this method on reducing the infection rate after TJA was systematically evaluated to provide a basis for future clinical work.

Methods

Using PubMed, Medline, Elsevier, and CNKI, with the following mesh words: “vancomycin”, “local / intraoperative / topical / intrawound”, “TJA”, “TKA”, “THA”, “total joint arthroplasty”, “total knee arthroplasty”, “total hip arthroplasty”, “infection”, and “SSI”, to search for case-control research papers on the impact of prophylactic application of vancomycin powder on the incidence of postoperative infection, we compared the overall infection rate in the literature by using RevMan 5.3 meta-analysis software and analyzed the impact of vancomycin on the infection rate of different parts and types of TJA according to different subgroups.

Results

A total of 22 qualified studies were selected; twenty-five studies compared the effect of prophylactic use of vancomycin powder on infection rates after TJA. There were 23,363 cases in total, including 9545 cases in the vancomycin group and 13,818 cases in the control group. The results of the meta-analysis showed that the possibility of postoperative infection after prophylactic use of vancomycin powder was significantly lower than that without vancomycin risk ratio: 0.38 [0.23,0.59], P < 0.01). However, a meta-analysis of randomized controlled trials (RCTs) showed no significant effect of vancomycin on postoperative infection (P = 0.52).

Conclusion

Based on the retrospective studies, local prophylactic use of vancomycin powder in TJA can significantly reduce the incidence of postoperative infection. High-quality RCTs should be carried out to further evaluate these results.
Literature
1.
go back to reference Ellison JJR, Boychuk LR, Chakravorty D, et al. A comparison of surgical site Infections following total hip replacement and total knee replacement surgeries identified by Infection Prevention and Control and the National Surgical Quality Improvement Program in Alberta, Canada[J]. Volume 43. Infection Control & Hospital Epidemiology; 2022. pp. 435–41. 4. Ellison JJR, Boychuk LR, Chakravorty D, et al. A comparison of surgical site Infections following total hip replacement and total knee replacement surgeries identified by Infection Prevention and Control and the National Surgical Quality Improvement Program in Alberta, Canada[J]. Volume 43. Infection Control & Hospital Epidemiology; 2022. pp. 435–41. 4.
2.
go back to reference Grammatico-Guillon L, Miliani K, Banaei-Bouchareb L, et al. A computerized indicator for surgical site Infection (SSI) assessment after total hip or total knee replacement: the French ISO-ORTHO indicator[J]. Infect Control Hosp Epidemiol. 2022;43(9):1171–8.CrossRefPubMed Grammatico-Guillon L, Miliani K, Banaei-Bouchareb L, et al. A computerized indicator for surgical site Infection (SSI) assessment after total hip or total knee replacement: the French ISO-ORTHO indicator[J]. Infect Control Hosp Epidemiol. 2022;43(9):1171–8.CrossRefPubMed
3.
go back to reference Adeyemi A, Trueman P. Economic burden of surgical site Infections within the episode of care following joint replacement[J]. J Orthop Surg Res. 2019;14:1–4.CrossRef Adeyemi A, Trueman P. Economic burden of surgical site Infections within the episode of care following joint replacement[J]. J Orthop Surg Res. 2019;14:1–4.CrossRef
4.
go back to reference Naqvi A, Chughtai M, Gwam C, et al. Decreasing the incidence of surgical-site Infections after total joint arthroplasty[J]. Am J Orthop. 2017;46(6):E374–87.PubMed Naqvi A, Chughtai M, Gwam C, et al. Decreasing the incidence of surgical-site Infections after total joint arthroplasty[J]. Am J Orthop. 2017;46(6):E374–87.PubMed
5.
go back to reference Sporer SM, Rogers T, Abella L. Methicillin-resistant and methicillin-sensitive Staphylococcus aureus screening and Decolonization to reduce surgical site Infection in elective total joint arthroplasty[J]. J Arthroplast. 2016;31(9):144–7.CrossRef Sporer SM, Rogers T, Abella L. Methicillin-resistant and methicillin-sensitive Staphylococcus aureus screening and Decolonization to reduce surgical site Infection in elective total joint arthroplasty[J]. J Arthroplast. 2016;31(9):144–7.CrossRef
6.
go back to reference Ashkenazi I, Thomas J, Lawrence KW, et al. Positive preoperative colonization with Methicillin Resistant Staphylococcus Aureus is Associated with Inferior postoperative outcomes in patients undergoing total joint Arthroplasty[J]. The Journal of Arthroplasty; 2023. Ashkenazi I, Thomas J, Lawrence KW, et al. Positive preoperative colonization with Methicillin Resistant Staphylococcus Aureus is Associated with Inferior postoperative outcomes in patients undergoing total joint Arthroplasty[J]. The Journal of Arthroplasty; 2023.
7.
go back to reference Siddiqi A, Forte SA, Docter S, et al. Perioperative antibiotic prophylaxis in total joint arthroplasty: a systematic review and meta-analysis[J]. JBJS. 2019;101(9):828–42.CrossRef Siddiqi A, Forte SA, Docter S, et al. Perioperative antibiotic prophylaxis in total joint arthroplasty: a systematic review and meta-analysis[J]. JBJS. 2019;101(9):828–42.CrossRef
8.
go back to reference Sewick A, Makani A, Wu C, et al. Does dual antibiotic prophylaxis better prevent surgical site Infections in total joint arthroplasty?[J]. Clin Orthop Relat Research®. 2012;470:2702–7.CrossRef Sewick A, Makani A, Wu C, et al. Does dual antibiotic prophylaxis better prevent surgical site Infections in total joint arthroplasty?[J]. Clin Orthop Relat Research®. 2012;470:2702–7.CrossRef
9.
go back to reference Heckmann ND, Mayfield CK, Culvern CN, et al. Systematic review and meta-analysis of intrawound Vancomycin in total hip and total knee arthroplasty: a call for a prospective randomized trial[J]. J Arthroplast. 2019;34(8):1815–22.CrossRef Heckmann ND, Mayfield CK, Culvern CN, et al. Systematic review and meta-analysis of intrawound Vancomycin in total hip and total knee arthroplasty: a call for a prospective randomized trial[J]. J Arthroplast. 2019;34(8):1815–22.CrossRef
10.
go back to reference Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses[J]. Volume 2. Ottawa: Ottawa Hospital Research Institute; 2011. pp. 1–12. 1. Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses[J]. Volume 2. Ottawa: Ottawa Hospital Research Institute; 2011. pp. 1–12. 1.
11.
go back to reference Abuzaiter W, Bolton CA, Drakos A, et al. Is topical Vancomycin an option? A Randomized Controlled Trial to Determine the Safety of the topical use of Vancomycin Powder in preventing postoperative Infections in total knee arthroplasty, as compared with standard postoperative Antibiotics[J]. J Arthroplast. 2023. https://doi.org/10.1016/j.arth.2023.01.040.CrossRef Abuzaiter W, Bolton CA, Drakos A, et al. Is topical Vancomycin an option? A Randomized Controlled Trial to Determine the Safety of the topical use of Vancomycin Powder in preventing postoperative Infections in total knee arthroplasty, as compared with standard postoperative Antibiotics[J]. J Arthroplast. 2023. https://​doi.​org/​10.​1016/​j.​arth.​2023.​01.​040.CrossRef
12.
go back to reference Aljuhani WS, Alanazi AM, Alghafees MA, et al. The efficacy of Vancomycin powder in total knee arthroplasty: a single-center study [J]. Saudi Med J. 2021;42(5):550.CrossRefPubMedPubMedCentral Aljuhani WS, Alanazi AM, Alghafees MA, et al. The efficacy of Vancomycin powder in total knee arthroplasty: a single-center study [J]. Saudi Med J. 2021;42(5):550.CrossRefPubMedPubMedCentral
13.
go back to reference Assor M. Noncemented total knee arthroplasty with a local prophylactic anti-infection agent: a prospective series of 135 cases [J]. Can J Surg. 2010;53(1):47.PubMedPubMedCentral Assor M. Noncemented total knee arthroplasty with a local prophylactic anti-infection agent: a prospective series of 135 cases [J]. Can J Surg. 2010;53(1):47.PubMedPubMedCentral
14.
go back to reference Cohen-Rosenblum A, Crutcher M, Gui J et al. Dual antibiotic therapy with Vancomycin and cefazolin for surgical prophylaxis in total knee arthroplasty[J]. Reconstr Rev, 2018, 8(2). Cohen-Rosenblum A, Crutcher M, Gui J et al. Dual antibiotic therapy with Vancomycin and cefazolin for surgical prophylaxis in total knee arthroplasty[J]. Reconstr Rev, 2018, 8(2).
15.
go back to reference Cohen EM, Marcaccio S, Goodman AD, Lemme NJ, Limbird R. Efficacy and cost-effectiveness of topical Vancomycin powder in primary Cementless total hip arthroplasty. Orthopedics. 2019;42(5):e430–6.CrossRefPubMed Cohen EM, Marcaccio S, Goodman AD, Lemme NJ, Limbird R. Efficacy and cost-effectiveness of topical Vancomycin powder in primary Cementless total hip arthroplasty. Orthopedics. 2019;42(5):e430–6.CrossRefPubMed
16.
go back to reference Crawford DA, Berend KR, Adams JB et al. Decreased incidence of periprosthetic joint Infection in total hip arthroplasty with use of topical vancomycin[J]. Reconstr Rev, 2018, 8(1). Crawford DA, Berend KR, Adams JB et al. Decreased incidence of periprosthetic joint Infection in total hip arthroplasty with use of topical vancomycin[J]. Reconstr Rev, 2018, 8(1).
17.
go back to reference Dial BL, Lampley AJ, Green CL, et al. Intrawound Vancomycin powder in primary total hip arthroplasty increases rate of sterile wound Complications [J]. Volume 30. Hip & pelvis; 2018. pp. 37–44. 1. Dial BL, Lampley AJ, Green CL, et al. Intrawound Vancomycin powder in primary total hip arthroplasty increases rate of sterile wound Complications [J]. Volume 30. Hip & pelvis; 2018. pp. 37–44. 1.
18.
go back to reference Duan MY, Zhang HZ. Vancomycin lavage for the incidence of acute surgical site Infection following primary total hip arthroplasty and total knee arthroplasty [J]. World J Clin Cases. 2022;10(1):71.CrossRefPubMedPubMedCentral Duan MY, Zhang HZ. Vancomycin lavage for the incidence of acute surgical site Infection following primary total hip arthroplasty and total knee arthroplasty [J]. World J Clin Cases. 2022;10(1):71.CrossRefPubMedPubMedCentral
19.
go back to reference Erken HY, Nusran G, Karagüven D et al. No decrease in Infection rate with the use of local Vancomycin powder after partial hip replacement in elderly patients with comorbidities[J]. Cureus, 2020, 12(9). Erken HY, Nusran G, Karagüven D et al. No decrease in Infection rate with the use of local Vancomycin powder after partial hip replacement in elderly patients with comorbidities[J]. Cureus, 2020, 12(9).
20.
go back to reference Hanada M, Nishikino S, Hotta K, et al. Intrawound Vancomycin powder increases post-operative wound Complications and does not decrease periprosthetic joint Infection in primary total and unicompartmental knee arthroplasties [J]. Volume 27. Arthroscopy: Knee Surgery, Sports Traumatology; 2019. pp. 2322–7. Hanada M, Nishikino S, Hotta K, et al. Intrawound Vancomycin powder increases post-operative wound Complications and does not decrease periprosthetic joint Infection in primary total and unicompartmental knee arthroplasties [J]. Volume 27. Arthroscopy: Knee Surgery, Sports Traumatology; 2019. pp. 2322–7.
21.
go back to reference Khatri K, Bansal D, Singla R, Sri S. Prophylactic intrawound application of Vancomycin in total knee arthroplasty. J Arthrosc Joint Surg. 2017;4(2):61–4.CrossRef Khatri K, Bansal D, Singla R, Sri S. Prophylactic intrawound application of Vancomycin in total knee arthroplasty. J Arthrosc Joint Surg. 2017;4(2):61–4.CrossRef
22.
go back to reference Koutalos AA, Drakos A, Fyllos A, et al. Does intra-wound Vancomycin powder affect the action of intra-articular tranexamic acid in total joint replacement? [J]. Microorganisms. 2020;8(5):671.CrossRefPubMedPubMedCentral Koutalos AA, Drakos A, Fyllos A, et al. Does intra-wound Vancomycin powder affect the action of intra-articular tranexamic acid in total joint replacement? [J]. Microorganisms. 2020;8(5):671.CrossRefPubMedPubMedCentral
23.
go back to reference Matziolis G, Brodt S, Böhle S, et al. Intraarticular Vancomycin powder is effective in preventing Infections following total hip and knee arthroplasty[J]. Sci Rep. 2020;10(1):1–6.CrossRef Matziolis G, Brodt S, Böhle S, et al. Intraarticular Vancomycin powder is effective in preventing Infections following total hip and knee arthroplasty[J]. Sci Rep. 2020;10(1):1–6.CrossRef
24.
go back to reference Otte JE, Politi JR, Chambers B, Smith CA. Intrawound Vancomycin powder reduces early prosthetic joint Infections in revision hip and knee arthroplasty. Surg Technol Int. 2017;30:284–9.PubMed Otte JE, Politi JR, Chambers B, Smith CA. Intrawound Vancomycin powder reduces early prosthetic joint Infections in revision hip and knee arthroplasty. Surg Technol Int. 2017;30:284–9.PubMed
25.
go back to reference Patel NN, Guild IIIGN, Kumar AR. Intrawound Vancomycin in primary hip and knee arthroplasty: a safe and cost-effective means to decrease early periprosthetic joint Infection [J]. Arthroplasty Today. 2018;4(4):479–83.CrossRefPubMedPubMedCentral Patel NN, Guild IIIGN, Kumar AR. Intrawound Vancomycin in primary hip and knee arthroplasty: a safe and cost-effective means to decrease early periprosthetic joint Infection [J]. Arthroplasty Today. 2018;4(4):479–83.CrossRefPubMedPubMedCentral
26.
go back to reference Riesgo AM, Park BK, Herrero CP, Yu S, Schwarzkopf R, Iorio R. Vancomycin Povidone-Iodine Protocol improves survivorship of Periprosthetic Joint Infection treated with irrigation and debridement. J Arthroplasty. 2018;33(3):847–50.CrossRefPubMed Riesgo AM, Park BK, Herrero CP, Yu S, Schwarzkopf R, Iorio R. Vancomycin Povidone-Iodine Protocol improves survivorship of Periprosthetic Joint Infection treated with irrigation and debridement. J Arthroplasty. 2018;33(3):847–50.CrossRefPubMed
27.
go back to reference Tahmasebi MN, Vaziri AS, Vosoughi F, et al. Low post-arthroplasty Infection rate is possible in developing countries: long-term experience of local Vancomycin use in Iran [J]. J Orthop Surg Res. 2021;16(1):1–7.CrossRef Tahmasebi MN, Vaziri AS, Vosoughi F, et al. Low post-arthroplasty Infection rate is possible in developing countries: long-term experience of local Vancomycin use in Iran [J]. J Orthop Surg Res. 2021;16(1):1–7.CrossRef
28.
go back to reference Wang Y, Li C, Peng K. Efficacy and safety of locally-applied Vancomycin powder injection for the prevention of prosthetic joint infection[J]. Trop J Pharm Res, 2023, 22(2). Wang Y, Li C, Peng K. Efficacy and safety of locally-applied Vancomycin powder injection for the prevention of prosthetic joint infection[J]. Trop J Pharm Res, 2023, 22(2).
29.
go back to reference Winkler C, Dennison J, Wooldridge A, et al. Do local antibiotics reduce periprosthetic joint Infections? A retrospective review of 744 cases. J Clin Orthop Trauma. 2018;9(Suppl 1):34–S39.CrossRef Winkler C, Dennison J, Wooldridge A, et al. Do local antibiotics reduce periprosthetic joint Infections? A retrospective review of 744 cases. J Clin Orthop Trauma. 2018;9(Suppl 1):34–S39.CrossRef
30.
go back to reference Wu X, Gu Q. Effectiveness and safety of Vancomycin powder injection locally applied in theprevention of prosthetic joint infection[J]. Indian J Experimental Biology (IJEB). 2022;60(07):538–42. Wu X, Gu Q. Effectiveness and safety of Vancomycin powder injection locally applied in theprevention of prosthetic joint infection[J]. Indian J Experimental Biology (IJEB). 2022;60(07):538–42.
31.
go back to reference Xu X, Zhang X, Zhang Y, et al. Role of intra-wound powdered Vancomycin in primary total knee arthroplasty [J]. Volume 106. Orthopaedics & Traumatology: Surgery & Research; 2020. pp. 417–20. 3. Xu X, Zhang X, Zhang Y, et al. Role of intra-wound powdered Vancomycin in primary total knee arthroplasty [J]. Volume 106. Orthopaedics & Traumatology: Surgery & Research; 2020. pp. 417–20. 3.
32.
go back to reference Yavuz IA, Oken OF, Yildirim AO, Inci F, Ceyhan E, Gurhan U. No effect of Vancomycin powder to prevent Infection in primary total knee arthroplasty: a retrospective review of 976 cases. Knee Surg Sports Traumatol Arthrosc. 2019;28(9):3055–60.CrossRefPubMed Yavuz IA, Oken OF, Yildirim AO, Inci F, Ceyhan E, Gurhan U. No effect of Vancomycin powder to prevent Infection in primary total knee arthroplasty: a retrospective review of 976 cases. Knee Surg Sports Traumatol Arthrosc. 2019;28(9):3055–60.CrossRefPubMed
33.
go back to reference Kurtz SM, Lau EC, Son MS, Chang ET, Zimmerli W, Parvizi J. Are we winning or losing the Battle with Periprosthetic Joint Infection: Trends in Periprosthetic Joint Infection and mortality risk for the Medicare Population. J Arthroplasty. 2018;33:3238–45.CrossRefPubMed Kurtz SM, Lau EC, Son MS, Chang ET, Zimmerli W, Parvizi J. Are we winning or losing the Battle with Periprosthetic Joint Infection: Trends in Periprosthetic Joint Infection and mortality risk for the Medicare Population. J Arthroplasty. 2018;33:3238–45.CrossRefPubMed
34.
go back to reference Pugely AJ, Martin CT, Gao Y, et al. The incidence of and risk factors for 30-day surgical site Infections following primary and revision total joint arthroplasty[J]. J Arthroplast. 2015;30(9):47–50.CrossRef Pugely AJ, Martin CT, Gao Y, et al. The incidence of and risk factors for 30-day surgical site Infections following primary and revision total joint arthroplasty[J]. J Arthroplast. 2015;30(9):47–50.CrossRef
35.
go back to reference Schwartz AM, Farley KX, Guild GN, Bradbury TL Jr. Projections and epidemiology of revision hip and knee arthroplasty in the United States to 2030. J Arthroplasty. 2020;35:79–S85.CrossRef Schwartz AM, Farley KX, Guild GN, Bradbury TL Jr. Projections and epidemiology of revision hip and knee arthroplasty in the United States to 2030. J Arthroplasty. 2020;35:79–S85.CrossRef
36.
go back to reference Zmistowski B, Karam JA, Durinka JB, Casper DS, Parvizi J. Periprosthetic joint Infection increases the risk of one-year mortality. J Bone Joint Surg Am. 2013;95:2177–84.CrossRefPubMed Zmistowski B, Karam JA, Durinka JB, Casper DS, Parvizi J. Periprosthetic joint Infection increases the risk of one-year mortality. J Bone Joint Surg Am. 2013;95:2177–84.CrossRefPubMed
37.
go back to reference Premkumar A, Kolin DA, Farley KX, Wilson JM, McLawhorn AS, Cross MB, Sculco PK. Projected Economic Burden of Periprosthetic Joint Infection of the hip and knee in the United States. J Arthroplasty. 2021;36:1484–1489e3.CrossRefPubMed Premkumar A, Kolin DA, Farley KX, Wilson JM, McLawhorn AS, Cross MB, Sculco PK. Projected Economic Burden of Periprosthetic Joint Infection of the hip and knee in the United States. J Arthroplasty. 2021;36:1484–1489e3.CrossRefPubMed
38.
go back to reference Brothers KM, Parker DM, Taguchi M, et al. Dose optimization in surgical prophylaxis: sub-inhibitory dosing of Vancomycin increases rates of biofilm formation and the rates of surgical site infection[J]. Sci Rep. 2023;13(1):4593.CrossRefPubMedPubMedCentral Brothers KM, Parker DM, Taguchi M, et al. Dose optimization in surgical prophylaxis: sub-inhibitory dosing of Vancomycin increases rates of biofilm formation and the rates of surgical site infection[J]. Sci Rep. 2023;13(1):4593.CrossRefPubMedPubMedCentral
39.
go back to reference Shu L, Muheremu A, Shoukeer K, et al. Prophylactic Application of Vancomycin Powder in preventing Surgical Site Infections after spinal Surgery[J]. World Neurosurg. 2023;171:e542–53.CrossRefPubMed Shu L, Muheremu A, Shoukeer K, et al. Prophylactic Application of Vancomycin Powder in preventing Surgical Site Infections after spinal Surgery[J]. World Neurosurg. 2023;171:e542–53.CrossRefPubMed
40.
go back to reference O’Toole RV, Joshi M, Carlini AR, et al. Effect of Intrawound Vancomycin powder in operatively treated high-risk tibia fractures: a randomized clinical trial[J]. JAMA Surg. 2021;156(5):e207259–9.CrossRefPubMed O’Toole RV, Joshi M, Carlini AR, et al. Effect of Intrawound Vancomycin powder in operatively treated high-risk tibia fractures: a randomized clinical trial[J]. JAMA Surg. 2021;156(5):e207259–9.CrossRefPubMed
41.
go back to reference Miquel J, Huang TB, Athwal GS, et al. Vancomycin is effective in preventing Cutibacterium acnes growth in a mimetic shoulder arthroplasty[J]. J Shoulder Elbow Surg. 2022;31(1):159–64.CrossRefPubMed Miquel J, Huang TB, Athwal GS, et al. Vancomycin is effective in preventing Cutibacterium acnes growth in a mimetic shoulder arthroplasty[J]. J Shoulder Elbow Surg. 2022;31(1):159–64.CrossRefPubMed
42.
go back to reference Edelstein AI, Weiner JA, Cook RW, Chun DS, Monroe E, Mitchell SM, Kannan A, Hsu WK, Stulberg SD, Hsu EL. Intra-articular vancomycin powder eliminates Methicillin-Resistant S. Aureus in a rat model of a contaminated Intra-articular Implant. J Bone Joint Surg Am. 2017;99:232–8.CrossRefPubMed Edelstein AI, Weiner JA, Cook RW, Chun DS, Monroe E, Mitchell SM, Kannan A, Hsu WK, Stulberg SD, Hsu EL. Intra-articular vancomycin powder eliminates Methicillin-Resistant S. Aureus in a rat model of a contaminated Intra-articular Implant. J Bone Joint Surg Am. 2017;99:232–8.CrossRefPubMed
Metadata
Title
Prophylactic use of vancomycin powder on postoperative infection after total joint arthroplasty
Authors
Jian Gao
Li Shu
Kan Jiang
Aikeremujiang Muheremu
Publication date
01-12-2024
Publisher
BioMed Central
Keyword
Vancomycin
Published in
BMC Musculoskeletal Disorders / Issue 1/2024
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-023-07024-2

Other articles of this Issue 1/2024

BMC Musculoskeletal Disorders 1/2024 Go to the issue